Search Results 751-760 of 17647 for protein intake optimization

  1. A Study To Assess A Change In Disease Activity And Adverse Events Of Intravenous Etentamig And Daratumumab (Etentamig+D) Compared To Daratumumab, Lenalidomide, And Dexamethasone (DRd) In Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible For Transplant - Mayo Clinic

    ... optimal dosages and risks/benefits. In the later ... Serum M-protein >= 0.5 g/dL (>= 5 g/L). Urine ... protein. Exclusion Criteria: Prior or current ...

  2. Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss

    ... optimal dosages and risks/benefits. In the later phase (phase 3) ... protein that forms plaques in the brains of people with Alzheimer Disease ...

  3. A Study to Evaluate Molecular Mechanisms of Exercise Benefits in Insulin Resistant People - Mayo Clinic

    About this study. The aim of the study is to investigate the effects of a 3-month resistance exercise program (in people aged 50 to 75) on muscle mass, ...

  4. Panobinostat and Everolimus in Treating Patients with Recurrent Multiple Myeloma, Non-Hodgkin Lymphoma, or Hodgkin Lymphoma - Mayo Clinic

    ... optimal dosages and risks/benefits. In the later ... Serum monoclonal protein ≥ 1.0 g/dL; ≥ 200 mg of ... requirements; Receiving corticosteroids ...

  5. The Effect of Blenderized Tube Feeding on Enteral Nutrition Tolerance and the Gut Microbiome - Mayo Clinic

    The purpose of this study is to examine the differences in percent of goal calories provided through blenderized tube feeding (BTF) and standard enteral formula ...

  6. Neurosurgery - Clinical trials

    ... protein CMVpp65. Cohort 1 includes blood ... Optimal Immunotargeting of MUC1 for Advanced Pancreatic Cancer” (Principal Investigator Dr. ... Students · Admissions ...

  7. Medical Research & Education - Mayo Clinic News Network

    Latest stories · Mayo Clinic research on remote hospital care for a rural or urban home setting featured image · Science Saturday: Blood Tube Optimization Program ...

  8. A Study of Imaging in Demyelinating Diseases - Mayo Clinic

    ... optimal dosages and risks/benefits. In the later ... Also, to measure neuroinflammation and microglial activity using translocator protein ... Meet the requirements ...

  9. Testing Teclistamab (TECVAYLI) In Combination With Iberdomide For Hard-to-Treat Multiple Myeloma - Mayo Clinic

    ... optimal dosages and risks/benefits. In the later ... A monoclonal antibody is a type of protein that ... requirements and provide mandatory blood and ...

  10. Oncology (Medical) - Clinical trials

    In general terms, scientists will study the cells, DNA, RNA, and proteins found in the tumor tissue and/or the blood to understand more about cancer and the ...